Vertex

Vertex’s Cystic-Fibrosis Drug Faces Big Test
Vertex’s Cystic-Fibrosis Drug Faces Big Test
WSJ Online
Vertex
cystic fibrosis
FDA
Orkambi
Flag link:
The top 10 most expensive drugs of 2013
The top 10 most expensive drugs of 2013
Fierce Pharma
drug pricing
Soliris
Alexion
Naglazyme
Biomarin
Kalydeco
Vertex
Cinryze
Shire
Sprycel
Bristol-Myers Squibb
Pomalyst
Celgene
Xyrem
Jazz Pharmaceuticals
Erbitux
Merck KGaA
Revlimid
Questcor
Mallinckrodt
H.P. Acthar Gel
Flag link:
Biotech Stocks Get Turbo Boost From Idenix Deal
Biotech Stocks Get Turbo Boost From Idenix Deal
Seeking Alpha
M&A
Merck
Idenix
Achillion
Agios
Alkermes
Celldex Therapeutics
Vertex
Seattle Genetics
Epizyme
Flag link:
Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014
Gilead Seeks To Expand Its Blockbuster Hepatitis Platforms In 2014
Seeking Alpha
Gilead Sciences
hepatitis C
Merck
Sovaldi
Vertex
Flag link:
Vertex Cystic Fibrosis Trial Has Good, Bad News
Vertex Cystic Fibrosis Trial Has Good, Bad News
Investors.com
Vertex
cystic fibrosis
Kalydeco
Flag link:
Vertex Building A Fortress In Cystic Fibrosis
Vertex Building A Fortress In Cystic Fibrosis
Investopedia
Vertex
cystic fibrosis
Gilead
GSK
Kalydeco
Bristol-Myers Squibb
Flag link:
Inside HCV: An Interview with Janssen
Inside HCV: An Interview with Janssen
Motley Fool
hepatitis C
Janssen
Gilead
JNJ
Vertex
simeprevir
sofosbuvir
Flag link:
Vertex strengthens warning with hepatitis C drug
Vertex strengthens warning with hepatitis C drug
Reuters
Vertex
hepatitis C
Incivek
Flag link:
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
Vertex to collaborate with Janssen on Phase 2 all-oral study for hepatitis C
The Fly on the Wall
Vertex
Janssen
hepatitis C
simeprevir
VX-135
Flag link:
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Cataract risk for kids on Vertex's cystic fibrosis pill -FDA
Reuters
cataracts
FDA
cystic fibrosis
Vertex
Kalydeco
Flag link:
Hepatitis C testing may lift Vertex’s market
Hepatitis C testing may lift Vertex’s market
The Boston Globe, MA
hepatitis C
Vertex
Incivek
Flag link:
An Assault On Vertex, Enthusiasm Building Around Xoma
An Assault On Vertex, Enthusiasm Building Around Xoma
Seeking Alpha
Xoma
Vertex
Flag link:
Vertex Could Fly High on Cystic Fibrosis Projects
Vertex Could Fly High on Cystic Fibrosis Projects
Motley Fool
cystic fibrosis
Vertex
Flag link:
Vertex's Cystic Fibrosis Drug Impresses Investors
Vertex's Cystic Fibrosis Drug Impresses Investors
Seeking Alpha
Vertex
cystic fibrosis
VX-809
Kalydeco
Flag link:
Vertex Is Ready To Rise On INCIVEK Success
Vertex Is Ready To Rise On INCIVEK Success
Seeking Alpha
Incivek
Vertex
hepatitis C
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Gilead
Merck
Pfizer
Flag link:
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
Vertex Hopes Two Cystic Fibrosis Drugs Better than One
TheStreet.com
cystic fibrosis
Vertex
Gilead
Bristol-Myers Squibb
Indenix
Kalydeco
VX-809
Flag link:
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C
Flag link:
J&J Open to Expanding Hepatitis C Collaboration With Vertex
J&J Open to Expanding Hepatitis C Collaboration With Vertex
Bloomberg
hepatitis C
JNJ
Vertex
Flag link:
Vertex: Watch New Hepatitis C Drug
Vertex: Watch New Hepatitis C Drug
Seeking Alpha
hepatitis C
Vertex
Incivek
Abbott Laboratories
Bristol-Myers Squibb
Gilead
Flag link:
3 Strong Biotech Stocks Better Than Keryx
3 Strong Biotech Stocks Better Than Keryx
Seeking Alpha
Keryx
Vertex
Achillion
Dendreon
Flag link:

Pages